Literature DB >> 2527513

Influence of various structural domains of fibrinogen and fibrin on the potentiation of plasminogen activation by recombinant tissue plasminogen activator.

V S de Serrano1, T Urano, P J Gaffney, F J Castellino.   

Abstract

Fibrinogen, fibrin, and related fragments have varying stimulatory effects on the initial rate of the activation of human plasminogen ([ Glu1]Pg) by recombinant tissue plasminogen activator (rt-PA). A detailed analysis of this enhancement was undertaken using various purified and complexed forms of the known domains of fibrin(ogen) with a view to gaining additional knowledge regarding the substructures of fibrinogen and fibrin that are important for their stimulatory capacities. Both arvin-mediated fibrin, as well as fibrinogen fragments generated as a result of its cleavage with CNBr, stimulate the activation in a biphasic manner, most likely as a result of changes in the promoter molecule accompanying the denaturation processes that are normally employed to either solubilize or generate these particular promoters. Using purified fibrinogen and fibrin fragments, it was found that fragment E, which binds to [Glu1]Pg, does not enhance the activation reaction, while fragment D1 has a potentiating effect. This suggests that the binding of [Glu1]Pg to fibrin(ogen) alone is not, in itself, sufficient for stimulation of activation to occur, but that the rt-PA-fibrin(ogen) interaction is fundamental to this same process. All purified and mixtures of fragments containing the fragment D domain (e.g., D2E, X-oligomer, fragment X) stimulate the reaction to a greater degree than fibrinogen and fragment D1. It is concluded that the fibrinogen D domain is a sine qua non for the enhancement reaction, while structures containing the E domain had a symbiotic effect on enhancement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527513     DOI: 10.1007/bf01025079

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  41 in total

1.  The lysis of crosslinked human fibrin by plasmin yields initially a single molecular complex, D dimer-E.

Authors:  P J Gaffney; F Joe
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

2.  The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.

Authors:  M A Lucas; D L Straight; L J Fretto; P A McKee
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

3.  Location of plasminogen-binding sites in human fibrin(ogen).

Authors:  A Váradi; L Patthy
Journal:  Biochemistry       Date:  1983-05-10       Impact factor: 3.162

4.  Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activator.

Authors:  F W Dunn; K Deguchi; J Soria; C Soria; H R Lijnen; G Tobelem; J Caen
Journal:  Thromb Res       Date:  1984-11-15       Impact factor: 3.944

5.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

6.  Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor.

Authors:  B Wiman; J Chmielewska; M Rånby
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

7.  Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen.

Authors:  Y Takada; Y Makino; A Takada
Journal:  Thromb Res       Date:  1985-08-01       Impact factor: 3.944

8.  Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator.

Authors:  E Suenson; L C Petersen
Journal:  Biochim Biophys Acta       Date:  1986-04-22

9.  Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.

Authors:  P C Harpel; T S Chang; E Verderber
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

10.  Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers.

Authors:  A P Laudano; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

View more
  3 in total

1.  Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation.

Authors:  J M Edelberg; M Weissler; S V Pizzo
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

2.  Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.

Authors:  P K Anonick; S L Gonias
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

3.  Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.

Authors:  J M Edelberg; S V Pizzo
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.